Press Releases

 
Press Releases
Date Title and Summary View
Jul 29, 2013 MADISON, Wisc. (July 29, 2013) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry Palmin, the company’s President and CEO and a Director, will step down from his positions with the company, in order to pur...
PDF
May 16, 2013 To Begin I-124-CLR1404 (LIGHT) Phase 2 Imaging Trial in Brain Cancer in Early 2014 Evaluating I-131-CLR1404 (HOT) Potential Phase 2 Indications and Trial Designs To File CLR1502 (GLOW2) IND for Intraoperative Tumor Margin Illumination by End 2013 ...
PDF
Feb 21, 2013 MADISON, Wisc. (February 21, 2013) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced the closing of a public offering of 11,000,000 units at $0.50 per unit for gross proceeds of $5,500,000. Each unit consisted of one shar...
PDF
Feb 13, 2013 MADISON, Wisc. (February 13, 2013) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced the pricing of a public offering of 11,000,000 units at $0.50 per unit for gross proceeds of $5,500,000. Each unit consists of one share...
PDF
Feb 4, 2013 MADISON, Wisc. (February 4, 2013) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry S. Palmin, President and CEO of Novelos, will present a corporate update at the 15th Annual BIO CEO & Investor Conference ...
PDF
Jan 31, 2013 Oral Presentation Highlights Cancer-Targeted PET Imaging, Therapeutic and Optical Imaging Compounds that Offer Broad-Spectrum Diagnosis and Treatment of Solid Tumors MADISON, Wisc. (January 31, 2013) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs ...
PDF
Nov 27, 2012 MADISON, Wisc. (November 27, 2012) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry Palmin, President and CEO of Novelos, will present a corporate update at the Benchmark 2012 Micro Cap Discovery Investor Conf...
PDF
Nov 5, 2012 Initiates Build-out of Manufacturing Facility for I-124-CLR1404 (LIGHT) MADISON, Wisc. (November 5, 2012) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced the closing of a private placement of e...
PDF
Oct 25, 2012 Expects Initial Imaging Results in First Quarter 2013 MADISON, Wisc. (October 25, 2012) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Cente...
PDF
Oct 3, 2012 Cancer-Targeted PET Imaging, Therapeutic and Optical Imaging Compounds Offer Broad-Spectrum Diagnosis and Treatment of Solid Tumors MADISON, Wisc. (October 3, 2012) – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of canc...
PDF
Page: FirstPrevious ...
15
NextLast